Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients?

PubWeight™: 1.25‹?› | Rank: Top 10%

🔗 View Article (PMC 2809795)

Published in Ann Surg Oncol on September 23, 2009

Authors

Douglas M Iddings1, Ani J Fleisig, Steven L Chen, Mark B Faries, Donald L Morton

Author Affiliations

1: Department of Surgical Oncology, Michigan State University, East Lansing, MI, USA. diddings181@yahoo.com

Articles citing this

Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol (2012) 1.64

Primary anorectal melanoma: an update. J Cancer (2012) 1.55

Characteristics and survival of korean anal cancer from the Korea central cancer registry data. Ann Coloproctol (2013) 1.38

Neoplasms of anal canal and perianal skin. Clin Colon Rectal Surg (2011) 1.28

Primary anorectal melanoma. Case Rep Oncol (2014) 1.13

Anorectal malignant melanomas: retrospective experience with surgical management. World J Gastroenterol (2011) 0.96

Locoregional lymphadenectomy in the surgical management of anorectal melanoma. Ann Surg Oncol (2013) 0.81

Incidence, Surgical Treatment, and Prognosis of Anorectal Melanoma From 1973 to 2011: A Population-Based SEER Analysis. Medicine (Baltimore) (2016) 0.81

Unexpected post-operative diagnosis of primary rectal melanoma. A case report. G Chir (2014) 0.78

Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition). Ann Transl Med (2015) 0.76

Anorectal malignant melanoma: curative abdominoperineal resection: patient selection with 18F-FDG-PET/CT. World J Surg Oncol (2016) 0.75

Identification of recurrent mutational events in anorectal melanoma. Mod Pathol (2016) 0.75

Evolving Therapeutic Strategies in Mucosal Melanoma Have Not Improved Survival Over Five Decades. Am Surg (2016) 0.75

Preliminary Suggestion about Staging of Anorectal Malignant Melanoma May Be Used to Predict Prognosis. Cancer Res Treat (2015) 0.75

Laparoscopic abdomino-perineal resection for patients with anorectal malignant melanoma: a report of 4 cases. J Biomed Res (2013) 0.75

Rectal melanoma: epidemiology, prognosis, and role of adjuvant radiation therapy. J Cancer Res Clin Oncol (2016) 0.75

Black Is the New Black: Prolapsing Primary Anorectal Melanoma. Dig Dis Sci (2017) 0.75

Articles cited by this

The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer (1998) 6.22

Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum (1995) 2.64

Wide local excision or abdominoperineal resection as the initial treatment for anorectal melanoma? Am J Surg (2005) 2.47

A comparison of wide local excision with abdominoperineal resection in anorectal melanoma. Melanoma Res (2004) 2.20

Surgical management of primary anorectal melanoma. Br J Surg (2004) 2.14

The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg (2006) 1.90

Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma. J Clin Oncol (2002) 1.65

Surgical therapy for anorectal melanoma. J Am Coll Surg (2003) 1.65

Patterns of failure in anorectal melanoma. A guide to surgical therapy. Arch Surg (1990) 1.64

Malignant melanoma of the anus: report of 12 patients and analysis of 255 additional cases. Dis Colon Rectum (1982) 1.58

Anorectal melanoma: surgical management guidelines according to tumour thickness. Br J Cancer (2003) 1.37

Factors affecting survival in patients with anal melanoma. Am Surg (2006) 1.03

Melanoma of the anal canal: a case series. Dis Colon Rectum (2007) 0.96

A comparative study of melanoma and epidermoid carcinoma of the anal canal: A review of 20 melanomas and 29 epidermoid carcinomas (1930 to 1965). Dis Colon Rectum (1967) 0.96

Noncutaneous melanoma. Malignant melanoma of the anorectum. CA Cancer J Clin (1966) 0.86

Articles by these authors

Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08

A landscape of driver mutations in melanoma. Cell (2012) 12.61

Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med (2014) 10.69

Sentinel node biopsy and standard of care for melanoma. J Am Acad Dermatol (2009) 4.32

Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program. J Am Coll Surg (2004) 3.65

Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clin Cancer Res (2008) 3.24

The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I). Ann Surg Oncol (2010) 3.02

Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma. J Clin Oncol (2008) 2.53

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol (2010) 2.30

Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. Ann Surg (2007) 2.28

An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin (2004) 2.18

Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas. Clin Cancer Res (2004) 2.05

Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Ann Surg Oncol (2006) 2.00

Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. Hum Mol Genet (2013) 1.95

Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). Ann Surg Oncol (2012) 1.92

Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation (2006) 1.86

Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients. Oncogene (2004) 1.81

Prolonged survival after complete resection of metastases from intraocular melanoma. Cancer (2004) 1.78

Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes. J Clin Oncol (2003) 1.78

Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol (2011) 1.78

CpG island methylator phenotype predicts progression of malignant melanoma. Clin Cancer Res (2009) 1.77

Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients. Clin Cancer Res (2006) 1.72

BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition. Proc Natl Acad Sci U S A (2013) 1.72

Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma. Ann Surg Oncol (2008) 1.66

Prognostic implications of thick (>or=4-mm) melanoma in the era of intraoperative lymphatic mapping and sentinel lymphadenectomy. Ann Surg Oncol (2002) 1.65

Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma. Epigenetics (2011) 1.55

Staging of regional lymph nodes in melanoma: a case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system. JAMA Surg (2013) 1.52

Contemporary surgical treatment of advanced-stage melanoma. Arch Surg (2004) 1.52

Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients. J Clin Oncol (2004) 1.50

An interaction of race and ethnicity with socioeconomic status in rectal cancer outcomes. Ann Surg (2011) 1.49

Peripheral blood CD4+ T-cell response before postoperative active immunotherapy correlates with clinical outcome in metastatic melanoma. Ann Surg Oncol (2004) 1.44

Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications. Cancer J (2002) 1.43

Systemic irinotecan and regional floxuridine after hepatic cytoreduction in 185 patients with unresectable colorectal cancer metastases. Ann Surg Oncol (2002) 1.42

Endoscopy education in general surgery residencies: meeting the new RRC requirements. J Surg Res (2010) 1.42

Preoperative imaging of pulmonary metastases in patients with melanoma: implications for minimally invasive techniques. Arch Surg (2012) 1.41

Serum TA90 immune complex assay can predict outcome after resection of thick (> or =4 mm) primary melanoma and sentinel lymphadenectomy. Ann Surg Oncol (2002) 1.39

Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine. J Clin Oncol (2002) 1.38

New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol (2003) 1.34

Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol (2004) 1.32

Authors' response to a letter to the editor re: Sentinel node biopsy for early-stage melanoma. Ann Surg (2007) 1.32

Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg (2006) 1.31

Anorectal malignant melanoma: extensive 45-year review and proposal for a novel staging classification. J Am Coll Surg (2013) 1.29

Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes. J Surg Oncol (2011) 1.29

Prospective multicenter trial of staging adequacy in colon cancer: preliminary results. Arch Surg (2006) 1.28

Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees. Ann Intern Med (2013) 1.26

Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas. Cancer Res (2003) 1.24

Endogenous immune response to gangliosides in patients with confined prostate cancer. Int J Cancer (2005) 1.23

Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors. Mol Cancer Ther (2008) 1.23

Age-related lymphatic dysfunction in melanoma patients. Ann Surg Oncol (2009) 1.22

The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making. Clin Nucl Med (2003) 1.21

Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma. J Clin Oncol (2004) 1.20

Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann Surg Oncol (2007) 1.19

Improved survival for stage IV melanoma from an unknown primary site. J Clin Oncol (2009) 1.18

Late recurrence in melanoma: clinical implications of lost dormancy. J Am Coll Surg (2013) 1.18

Effect of lymphatic mapping on the new tumor-node-metastasis classification for colorectal cancer. J Clin Oncol (2003) 1.18

Estrogen receptor-alpha methylation predicts melanoma progression. Cancer Res (2006) 1.18

Surgical resident involvement is safe for common elective general surgery procedures. J Am Coll Surg (2011) 1.17

Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine. Clin Cancer Res (2009) 1.17

Melanoma recurrence patterns after negative sentinel lymphadenectomy. Arch Surg (2005) 1.15

Glycoimmunomics of human cancer: current concepts and future perspectives. Future Oncol (2007) 1.14

Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma. J Clin Oncol (2005) 1.12

Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma. Ann Surg Oncol (2012) 1.11

Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes. Clin Cancer Res (2005) 1.11

Immune responses in the draining lymph nodes against cancer: implications for immunotherapy. Cancer Metastasis Rev (2006) 1.11

Importance of sentinel lymph node biopsy in patients with thin melanoma. Arch Surg (2008) 1.10

AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome. J Invest Dermatol (2012) 1.09

Lack of Insurance is Associated With Increased Risk for Hernia Complications. Ann Surg (2009) 1.09

Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes. Clin Cancer Res (2008) 1.09

Adjuvant radiation therapy is associated with improved survival for adenoid cystic carcinoma of the breast. J Surg Oncol (2010) 1.08

mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beads. Clin Chem (2009) 1.07

B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma. J Invest Dermatol (2013) 1.07

An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma. Am Surg (2010) 1.05

Surgery for distant melanoma metastasis. Cancer J (2012) 1.03

Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine. Int J Cancer (2005) 1.03

Local and intralesional therapy of in-transit melanoma metastases. J Surg Oncol (2011) 1.03

Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream. Melanoma Res (2011) 1.03

Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial. J Clin Oncol (2012) 1.01

Vaccine therapy for melanoma: current status and future directions. Vaccine (2007) 1.00

Allelic imbalance of 12q22-23 associated with APAF-1 locus correlates with poor disease outcome in cutaneous melanoma. Cancer Res (2004) 1.00

Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute. J Surg Oncol (2010) 1.00

Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention. Ann Surg (2011) 0.99

Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma. Clin Cancer Res (2007) 0.99

The role of sentinel lymph node biopsy in the management of melanoma. Adv Surg (2007) 0.98

Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma. Cancer Immunol Immunother (2003) 0.98

Combined intralesional Bacille Calmette-Guérin (BCG) and topical imiquimod for in-transit melanoma. J Immunother (2012) 0.98